Nova Patents
PL347906A1

Flow resistance modulated aerosolized active agent delivery

Abstract

The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at a low inspiratory flow rate for an initial period of time to increase bioavailability of the active agent.

Term

Term ended

Projected expiry passed 7 October 2019, 7 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

80 members in 51 offices

This recordMember, by publication datePriority claim41 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
10370298United States of AmericaP
10370298United States of AmericaP
9923698United States of AmericaW
9923698United States of AmericaW
9860103702–––
99US9923698–––
US19980103702P–––
WO1999US23698–––

Members80

Family members, oldest first
DocumentOfficeKind
UY25731A1UruguayA1
CA2346791A1CanadaA1
WO0021594A2World Intellectual Property Organization (WIPO)A2
AU1202800AAustraliaA
WO0021594A3World Intellectual Property Organization (WIPO)A3
PA8484001A1PanamaA1
PE20001281A1PeruA1
IS5904AIcelandA
GT199900174AGuatemalaA
NO20011742D0NorwayD0
ID28354AIndonesiaA
NO20011742LNorwayL
BR9914384ABrazilA
LV12685ALatviaA
CO5060481A1ColombiaA1
EP1119384A2European Patent Office (EPO)A2
KR20010075568ARepublic of KoreaA
CZ20011181A3CzechiaA3
ZA200102766BSouth AfricaB
SK4772001A3SlovakiaA3
LV12685BLatviaB
EA200100338A1Eurasian Patent Organization (EAPO)A1
TR200101033T2TürkiyeT2
BG105377ABulgariaA
LT2001051ALithuaniaA
LT2001057ALithuaniaA
HU0103805A2HungaryA2
HUP0103805A2HungaryA2
LT4902BLithuaniaB
PL347906A1This recordPolandA1
LT4907BLithuaniaB
AR020760A1ArgentinaA1
EE200100212AEstoniaA
HK1040645A1Hong Kong, ChinaA1
HRP20010253A2CroatiaA2
EG22111AEgyptA
JP2002527151AJapanA
HU0103805A3HungaryA3
HUP0103805A3HungaryA3
US2002168322A1United States of AmericaA1
AU754724B2AustraliaB2
YU26101AYugoslavia, later Serbia and Montenegro (until 2006)A
EA003405B1Eurasian Patent Organization (EAPO)B1
NZ510853ANew ZealandA
MA25865A1MoroccoA1
CN1447704AChinaA
GEP20043259BGeorgiaB
DZ2906A1AlgeriaA1
EP1119384B1European Patent Office (EPO)B1
AT297771TAustriaT
ATE297771T1AustriaT1
DE69925849D1GermanyD1
OA11791AAfrican Intellectual Property Organization (OAPI)A
DK1119384T3DenmarkT3
PT1119384EPortugalE
UA73924C2UkraineC2
TNSN99188A1TunisiaA1
ES2243094T3SpainT3
HK1040645BHong Kong, ChinaB
RO120532B1RomaniaB1
EE04608B1EstoniaB1
DE69925849T2GermanyT2
HU225057B1HungaryB1
AP1646AAfrican Regional Intellectual Property Organization (ARIPO)A
KR100652532B1Republic of KoreaB1
SA1642B1Saudi ArabiaB1
SA99200835B1Saudi ArabiaB1
HRP20010253B1CroatiaB1
MY129112AMalaysiaA
PL193881B1PolandB1
IL142215AIsraelA
IS2289BIcelandB
CA2346791CCanadaC
RS49848BSerbiaB
JP2009136688AJapanA
SK287044B6SlovakiaB6
JP4378057B2JapanB2
CN101804230AChinaA
CN101804230BChinaB
US8408200B2United States of AmericaB2